Overview
The apex of the heart anterior to the cardiac base is an anatomical consideration rather than a clinical condition. This positioning can influence diagnostic imaging interpretation and procedural approaches, particularly in veterinary contexts where heart-base masses are evaluated 1.Diagnosis
Echocardiography: Essential for identifying masses and assessing cardiac function 1.
Clinical signs: Include retching/coughing, exercise intolerance, collapse, pericardial effusion, arrhythmias, and respiratory distress 1.
Imaging: Additional imaging like CT or MRI may be required for precise localization and staging 1.Management
Radiotherapy:
- Conventional Fractionated Radiotherapy (CFRT): 50 Gy in 20 fractions 1.
- Stereotactic Body Radiotherapy (SBRT): 30 Gy in 5 fractions or 24 Gy in 3 fractions 1.
Chemotherapy: Considered adjunctively post-radiation in some cases 1.Special Populations
No specific data: The provided abstracts do not cover special populations such as pregnancy, pediatrics, elderly, or comorbidities 1.Key Recommendations
Use echocardiography as the primary diagnostic tool for suspected heart-base masses in dogs 1.
Consider stereotactic body radiotherapy (SBRT) with doses of 30 Gy in 5 fractions or 24 Gy in 3 fractions for localized heart-base tumors, given its potential for improved survival outcomes 1 (Evidence: Moderate).
Evaluate the role of chemotherapy post-radiotherapy on a case-by-case basis, considering tumor type and patient status 1 (Evidence: Weak).References
1 Hansen KS, Théon AP, Willcox JL, Stern JA, Kent MS. Long-term outcomes with conventional fractionated and stereotactic radiotherapy for suspected heart-base tumours in dogs. Veterinary and comparative oncology 2021. link